Insider Trading & Ownership - GT Biopharma, Inc. (GTBP)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for GT Biopharma, Inc.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-04-11
Purchase		2023-04-11
6:59 pm		GT Biopharma Inc.GTBPBreen Michael Martin
Executive Chairman/Interim CEO		50,000$0.5$25,000656,218
(Direct)		View
2023-04-06
Purchase		2023-04-10
5:26 pm		GT Biopharma Inc.GTBPOhri Manu
CFO & Secretary		50,000$0.5$25,000150,000
(Indirect)		View
2020-11-16
Purchase		2021-10-07
2:47 pm		GT Biopharma Inc.GTBPWendel Bruce
Director		5,083$5.1739$26,299402,655
(Direct)		View
2020-12-21
Sale		2020-12-23
4:24 pm		GT Biopharma Inc.GTBPWeldon Steven W
Former Officer and Director		183,700$0.34206$62,8373,720,000
(Direct)		View
2020-12-16
Sale		2020-12-18
4:24 pm		GT Biopharma Inc.GTBPWeldon Steven W
Former Officer and Director		200,000$0.3025$60,5003,903,700
(Direct)		View
2020-12-11
Sale		2020-12-15
5:40 pm		GT Biopharma Inc.GTBPWeldon Steven W
Former Officer and Director		396,300$0.28621$113,4274,103,700
(Direct)		View
2020-06-02
Sale		2020-06-04
5:15 pm		GT Biopharma Inc.GTBPCataldo Tony
CEO
10% Owner		4,234,320$0.001$4,2346,500,000
(Direct)		View
2020-05-13
Sale		2020-05-14
1:40 pm		GT Biopharma Inc.GTBPWeldon Steven W
CFO		2,269,708$0.001$2,2704,500,000
(Direct)		View
2019-02-01
Sale		2019-03-19
2:38 pm		GT Biopharma Inc.GTBPUrbanski Raymond W.
CEO		176,980$0.001$1771,351,918
(Direct)		View
2019-02-06
Sale		2019-02-13
11:22 am		GT Biopharma Inc.GTBPCataldo Tony
Director		800,000$0.001$8004,029,600
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-08-11
Option Award		2023-08-15
7:29 pm		N/A
N/A		GT Biopharma Inc.GTBPBreen Michael Martin
Executive Chairman/Interim CEO		200,000$0.287856,218
(Direct)		View
2023-08-11
Option Award		2023-08-15
7:26 pm		N/A
N/A		GT Biopharma Inc.GTBPOhri Manu
CFO & Secretary		200,000$0.287750,000
(Direct)		View
2023-08-11
Other		2023-08-15
7:26 pm		N/A
N/A		GT Biopharma Inc.GTBPOhri Manu
CFO & Secretary		200,000$0.287750,000
(Direct)		View
2023-06-16
Option Award		2023-06-21
7:58 pm		N/A
2033-06-15		GT Biopharma Inc.GTBPCASAMENTO CHARLES J
Director		500,000$0500,000
(Direct)		View
2023-01-27
Option Award		2023-02-01
06:05 am		N/A
2033-01-26		GT Biopharma Inc.GTBPBreen Michael Martin
Exec Chairman and Interim CEO		500,000$0500,000
(Direct)		View
2023-01-27
Option Award		2023-02-01
06:02 am		N/A
2033-01-26		GT Biopharma Inc.GTBPOhri Manu
Chief Financial Officer		500,000$0500,000
(Direct)		View
2023-01-27
Option Award		2023-02-01
06:02 am		N/A
2033-01-26		GT Biopharma Inc.GTBPSHROTRIYA RAJESH C MD
Director		500,000$0500,000
(Direct)		View
2023-01-27
Option Award		2023-02-01
06:01 am		N/A
2033-01-26		GT Biopharma Inc.GTBPWendel Bruce
Director		500,000$0500,000
(Direct)		View
2022-07-15
Option Award		2022-07-19
9:48 pm		2022-07-15
2032-07-14		GT Biopharma Inc.GTBPBreen Michael Martin
Exec. Chair. and Interim CEO		328,058$0656,218
(Direct)		View
2022-07-15
Option Award		2022-07-19
9:46 pm		2022-07-15
2032-07-14		GT Biopharma Inc.GTBPSHROTRIYA RAJESH C MD
Director		461,476$0461,476
(Direct)		View
2022-07-15
Option Award		2022-07-19
9:46 pm		N/A
2032-07-14		GT Biopharma Inc.GTBPURBAN ALAN LOUIS
Director		50,000$050,000
(Direct)		View
2022-07-15
Option Award		2022-07-19
9:44 pm		2022-07-15
2032-07-14		GT Biopharma Inc.GTBPBerk Gregory
Pres. of R&D, CMO		50,000$050,000
(Direct)		View
2022-07-15
Other		2022-07-19
9:44 pm		N/A
N/A		GT Biopharma Inc.GTBPOhri Manu
CFO & Secretary		100,000$0500,000
(Direct)		View
2022-07-15
Option Award		2022-07-19
9:44 pm		N/A
2032-07-14		GT Biopharma Inc.GTBPOhri Manu
CFO & Secretary		300,000$0500,000
(Direct)		View
2022-07-15
Option Award		2022-07-19
9:42 pm		2022-07-15
2032-07-14		GT Biopharma Inc.GTBPWendel Bruce
Director		100,000$0100,000
(Direct)		View
2021-02-16
Option Award		2022-02-14
5:10 pm		N/A
2031-02-15		GT Biopharma Inc.GTBPBerk Gregory
Director		328,058$0328,058
(Direct)		View
2021-02-16
Option Award		2022-02-14
4:13 pm		N/A
2031-02-15		GT Biopharma Inc.GTBPSHROTRIYA RAJESH C MD
Director		50,000$050,000
(Direct)		View
2021-12-31
Option Award		2022-02-14
4:09 pm		N/A
2031-12-31		GT Biopharma Inc.GTBPChoy Gavin
Acting Chief Financial Officer		227,500$0227,500
(Direct)		View
2021-02-25
Conversion		2021-11-12
12:01 pm		N/A
N/A		GT Biopharma Inc.GTBPBreen Michael Martin
Director		50,102$3.4378,160
(Direct)		View
2021-02-25
Conversion		2021-11-12
12:01 pm		2018-09-07
N/A		GT Biopharma Inc.GTBPBreen Michael Martin
Director		130,000$0378,160
(Direct)		View
2021-02-16
Option Award		2021-11-12
12:01 pm		N/A
2031-02-15		GT Biopharma Inc.GTBPBreen Michael Martin
Director		328,058$0378,160
(Direct)		View

Ownership		2021-11-12
12:01 pm		2018-09-07
N/A		GT Biopharma Inc.GTBPBreen Michael Martin
Director		0$00
(Direct)		View
2021-02-16
Option Award		2021-10-07
2:47 pm		N/A
2031-02-15		GT Biopharma Inc.GTBPWendel Bruce
Director		397,572$0402,655
(Direct)		View
2019-08-14
Option Award		2019-08-16
4:57 pm		N/A
N/A		GT Biopharma Inc.GTBPCataldo Tony
CEO
10% Owner		7,000,000$010,734,320
(Direct)		View
2019-08-14
Option Award		2019-08-16
4:51 pm		N/A
N/A		GT Biopharma Inc.GTBPWeldon Steven W
CFO
10% Owner		4,500,000$06,769,707
(Direct)		View